Sun, Zhenni
Zhou, Mi
Yao, Yasai
Chen, Xuehong
Qin, Tao
Han, Yafei
Yue, Lu
Yao, Ruyong
Article History
Received: 13 November 2024
Accepted: 9 September 2025
First Online: 29 September 2025
Declarations
:
: The Qingdao Municipal Hospital Ethics Committee (approval number: 2023-092) approved the study protocol, which included clinical data collection, pathological review, and molecular studies. And all patients were consented to participate and provided written consent.
: All the authors have read and approved the final article.
: The authors declare no competing interests.